Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-06 Sale |
2023-03-08 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
65,966 | $9.5536 | $630,216 | 2,974 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:38 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
63,383 | $9.8866 | $626,642 | 21,404 (Direct) |
View |
| 2022-07-28 Sale |
2022-07-29 07:02 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
58,163 | $9.0365 | $525,590 | 2,974 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:13 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
32,311 | $7.45 | $240,718 | 263,012 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:54 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
6,452 | $8.1422 | $52,533 | 58,240 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:13 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
6,110 | $9.0602 | $55,358 | 47,341 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 07:48 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
37,884 | $10.22 | $387,125 | 2,974 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
13,930 | $10.57 | $147,186 | 111,633 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:10 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
18,430 | $10.83 | $199,612 | 58,264 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
3,926 | $11.12 | $43,669 | 2,974 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
65,312 | $12.69 | $829,103 | 53,396 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-07 Option Award |
2024-11-12 6:01 pm |
N/A 2034-11-07 |
Assertio Holdings Inc. | ASRT | Stark David Matthew Director |
134,975 | $0 | 134,975 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:14 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
65,966 | $0 | 299,470 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:14 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
94,621 | $0 | 299,470 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:38 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
63,383 | $0 | 21,404 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:06 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
44,953 | $0 | 44,953 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
72,068 | $0 | 263,012 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
127,345 | $0 | 263,012 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:54 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
18,430 | $0 | 58,240 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
12,538 | $0 | 47,341 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
37,939 | $0 | 47,341 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 07:48 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
37,884 | $0 | 2,974 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
13,930 | $0 | 111,633 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
80,798 | $0 | 111,633 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
18,430 | $0 | 58,264 (Direct) |
View |
| 2021-02-14 Exercise |
2021-02-17 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
3,926 | $0 | 2,974 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
12,538 | $0 | 53,396 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-11 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
90,658 | $0 | 53,396 (Direct) |
View |